Monopar Therapeutics
MNPR
#7784
Rank
โ‚ฌ0.22 B
Marketcap
36,53ย โ‚ฌ
Share price
1.92%
Change (1 day)
1,103.55%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -0,73ย โ‚ฌ

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -0,68ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,73ย โ‚ฌ a decrease over its 2021 EPS that were of -0,65ย โ‚ฌ.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,73ย โ‚ฌ0.02%
2022-0,73ย โ‚ฌ12.16%
2021-0,65ย โ‚ฌ27.59%
2020-0,51ย โ‚ฌ43.71%
2019-0,35ย โ‚ฌ33.52%
2018-0,27ย โ‚ฌ-80.97%
2017-1,40ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,91ย โ‚ฌ 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA